Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
After finishing at $44.2 in the prior trading day, Kymera Therapeutics Inc (NASDAQ: KYMR) closed at $43.7, down -1.13%. In other words, the price has decreased by -$1.13 from its previous closing price. On the day, 0.6 million shares were traded. KYMR stock price reached its highest trading level at $44.57 during the session, while it also had its lowest trading level at $43.21.
Ratios:
Our goal is to gain a better understanding of KYMR by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 8.49 and its Current Ratio is at 8.49. In the meantime, Its Debt-to-Equity ratio is 0.11 whereas as Long-Term Debt/Eq ratio is at 0.09.
On June 03, 2025, Morgan Stanley Upgraded its rating to Overweight which previously was Equal-Weight but kept the price unchanged to $79.
B. Riley Securities Upgraded its Neutral to Buy on June 03, 2025, while the target price for the stock was maintained at $60.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 30 ’25 when BVF PARTNERS L P/IL bought 317,167 shares for $44.00 per share. The transaction valued at 13,955,348 led to the insider holds 2,798,795 shares of the business.
BAKER BROS. ADVISORS LP bought 655,500 shares of KYMR for $28,842,000 on Jun 30 ’25. The Director now owns 6,117,295 shares after completing the transaction at $44.00 per share. On Jun 11 ’25, another insider, Ridloff Elena, who serves as the Director of the company, sold 4,500 shares for $50.00 each. As a result, the insider received 225,000 and left with 0 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, KYMR now has a Market Capitalization of 3065869568 and an Enterprise Value of 2468905216. For the stock, the TTM Price-to-Sale (P/S) ratio is 52.07 while its Price-to-Book (P/B) ratio in mrq is 3.62. Its current Enterprise Value per Revenue stands at 41.928 whereas that against EBITDA is -9.088.
Stock Price History:
The Beta on a monthly basis for KYMR is 2.18, which has changed by -0.054112554 over the last 52 weeks, in comparison to a change of 0.15366066 over the same period for the S&P500. Over the past 52 weeks, KYMR has reached a high of $53.27, while it has fallen to a 52-week low of $19.44. The 50-Day Moving Average of the stock is 2.94%, while the 200-Day Moving Average is calculated to be 11.34%.
Shares Statistics:
The stock has traded on average 863.78K shares per day over the past 3-months and 502650 shares per day over the last 10 days, according to various share statistics. A total of 65.11M shares are outstanding, with a floating share count of 58.31M. Insiders hold about 16.89% of the company’s shares, while institutions hold 90.45% stake in the company. Shares short for KYMR as of 1752537600 were 7572642 with a Short Ratio of 8.77, compared to 1749772800 on 7582895. Therefore, it implies a Short% of Shares Outstanding of 7572642 and a Short% of Float of 13.38.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0